Decision To Evaluate a Petition To Designate a Class of Employees at Monsanto Chemical Company, Dayton, Ohio, To Be included in the Special Exposure Cohort, 29336 [E6-7777]
Download as PDF
<![CDATA[
29336
Federal Register / Vol. 71, No. 98 / Monday, May 22, 2006 / Notices
in households at high risk for fire and
fire-related injury and death. Programs
of this type are thought to prevent firerelated injury and mortality, but have
not been studied scientifically to assess
their impact on fire-related injury
outcomes. The proposed study
represents the first formal effort to
evaluate the effectiveness and cost
implications of the SAIFE program as
implemented in North Carolina. The
data collected in this study will have
the potential to impact other smoke
alarm installation programs, as well as
indicate future priorities in prevention
and preparedness for residential fires.
There are no costs to the respondents
other than their time. The total
estimated annualized burden hours are
251.
ESTIMATED ANNUALIZED BURDEN HOURS
No. of respondents
Respondents
Adult male and female (age 18+ years) screened ......................................................................
Adult male and female (age 18+ years) Pre/Post Evaluation survey .........................................
Adult male and female (age 18+ years) household visit .............................................................
Dated: May 8, 2006.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–7732 Filed 5–19–06; 8:45 am]
not a toll-free number). Information
requests can also be submitted by e-mail
to OCAS@CDC.GOV.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. E6–7777 Filed 5–19–06; 8:45 am]
BILLING CODE 4163–19–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Decision To Evaluate a Petition To
Designate a Class of Employees at
Monsanto Chemical Company, Dayton,
Ohio, To Be included in the Special
Exposure Cohort
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
cchase on PROD1PC60 with NOTICES
AGENCY:
SUMMARY: The Department of Health and
Human Services (HHS) gives notice as
required by 42 CFR 83.12(e) of a
decision to evaluate a petition to
designate a class of employees at
Monsanto Chemical Company, Dayton,
Ohio, to be included in the Special
Exposure Cohort under the Energy
Employees Occupational Illness
Compensation Program Act of 2000. The
initial proposed definition for the class
being evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Monsanto Chemical
Company.
Location: Dayton, Ohio.
Job Titles and/or Job Duties: Directors
and subordinates, physicists, chemists,
technicians, and workers.
Period of Employment: 1943–1949.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health, 4676 Columbia
Parkway, MS C–46, Cincinnati, OH
45226, Telephone 513–533–6800 (this is
VerDate Aug<31>2005
21:00 May 19, 2006
Jkt 208001
Centers for Medicare & Medicaid
Services
Privacy Act of 1974; Report of a New
System of Records
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice of a New System of
Records (SOR).
AGENCY:
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
we are proposing to establish a new
SOR titled, ‘‘Organ Procurement
Organizations System (OPOS), System
No. 09–70–0575.’’ The Organ
Procurement Organization (OPO)
Certification Act of 2000 (§ 701 of Pub.
L. 106–505) directs the Secretary of HHS
to establish regulations that provide the
statutory qualifications and
requirements that an OPO must meet in
order for organ procurement costs to be
reimbursed under the Medicare and
Medicaid programs. As part of the
efficient administration of this program,
CMS is charged with the responsibility
to conduct investigations, analysis, and
reporting of adverse events that are
described as an untoward, undesirable,
and unanticipated event that causes
death or serious injury. At this time,
individually-identifiable data is only
requested from OPOs under two
circumstances: (1) Due to the suspicion
that an infectious disease has been
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
425
360
36
Average burden per response
(in hours).
No. of responses per
respondent
1
2
1
5/60
15/60
1
transmitted to a recipient; and (2) when
there has been a complaint alleged
against an OPO. CMS regional office
survey and certification staff would
request individually-identifiable data to
complete the investigation. Due to
certain investigatory activities related to
this system, CMS proposes to exempt
this system from the notification, access,
correction and amendment provisions of
the Privacy Act of 1974.
The purpose of this system is to
collect and maintain individually
identifiable information pertaining to
complaint allegations filed by a
complainant, beneficiary, or providers
of services made against OPOs,
information gathered during the
complaint investigation, findings and
results of the investigation, and
correspondence relating to the outcome
of the investigation. Information
retrieved from this system will also be
disclosed to: (1) Support regulatory,
reimbursement, and policy functions
performed within the agency, or by a
contractor, consultant or grantee; (2)
assist another Federal or state agency in
the enforcement of OPO regulations
where sharing the information is
necessary to complete the processing of
a complaint, contribute to the accuracy
of CMS’s proper payment of Medicare
benefits, and/or enable such agency to
administer a Federal health benefits
program; (3) support constituent
requests made to a Congressional
representative; and (4) support litigation
involving the agency. We have provided
background information about the
modified system in the ‘‘Supplementary
Information’’ section below. Although
the Privacy Act requires only that CMS
provide an opportunity for interested
persons to comment on the proposed
routine uses, CMS invites comments on
all portions of this notice. See ‘‘Effective
Dates’’ section for comment period.
Effective Date: CMS filed a new
SOR report with the Chair of the House
DATES:
E:\FR\FM\22MYN1.SGM
22MYN1
]]>Agencies
[Federal Register Volume 71, Number 98 (Monday, May 22, 2006)]
[Notices]
[Page 29336]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7777]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Decision To Evaluate a Petition To Designate a Class of Employees
at Monsanto Chemical Company, Dayton, Ohio, To Be included in the
Special Exposure Cohort
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS) gives notice
as required by 42 CFR 83.12(e) of a decision to evaluate a petition to
designate a class of employees at Monsanto Chemical Company, Dayton,
Ohio, to be included in the Special Exposure Cohort under the Energy
Employees Occupational Illness Compensation Program Act of 2000. The
initial proposed definition for the class being evaluated, subject to
revision as warranted by the evaluation, is as follows:
Facility: Monsanto Chemical Company.
Location: Dayton, Ohio.
Job Titles and/or Job Duties: Directors and subordinates,
physicists, chemists, technicians, and workers.
Period of Employment: 1943-1949.
FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of
Compensation Analysis and Support, National Institute for Occupational
Safety and Health, 4676 Columbia Parkway, MS C-46, Cincinnati, OH
45226, Telephone 513-533-6800 (this is not a toll-free number).
Information requests can also be submitted by e-mail to OCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. E6-7777 Filed 5-19-06; 8:45 am]
BILLING CODE 4163-19-P
